Pian Liu

813 total citations
29 papers, 533 citations indexed

About

Pian Liu is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Pian Liu has authored 29 papers receiving a total of 533 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 12 papers in Oncology and 9 papers in Cancer Research. Recurrent topics in Pian Liu's work include Ferroptosis and cancer prognosis (4 papers), Cancer-related Molecular Pathways (4 papers) and PI3K/AKT/mTOR signaling in cancer (3 papers). Pian Liu is often cited by papers focused on Ferroptosis and cancer prognosis (4 papers), Cancer-related Molecular Pathways (4 papers) and PI3K/AKT/mTOR signaling in cancer (3 papers). Pian Liu collaborates with scholars based in China, Sweden and United States. Pian Liu's co-authors include Shaobo Hu, Bing-Fei Xu, Shao-Hua Xie, Xin Jin, Xiang Cheng, Tianyi Gao, Chen Zhang, Chen Zhang, Zifang Song and Shi Lu and has published in prestigious journals such as Journal of Clinical Investigation, Molecular Cell and Cancer Research.

In The Last Decade

Pian Liu

28 papers receiving 529 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Pian Liu China	13	317	135	114	77	73	29	533
Shuzhen Chen China	10	234 0.7×	147 1.1×	109 1.0×	67 0.9×	32 0.4×	13	481
Allen Zhang United States	10	397 1.3×	141 1.0×	133 1.2×	31 0.4×	47 0.6×	16	565
Ying Cheng China	15	238 0.8×	174 1.3×	117 1.0×	61 0.8×	24 0.3×	48	605
Macus Hao‐Ran Bao Hong Kong	7	372 1.2×	304 2.3×	92 0.8×	51 0.7×	51 0.7×	8	607
Qian Qiao China	12	239 0.8×	53 0.4×	66 0.6×	74 1.0×	39 0.5×	25	439
Guangyuan Song China	16	328 1.0×	210 1.6×	153 1.3×	94 1.2×	27 0.4×	47	621
Anwen Liu China	13	276 0.9×	135 1.0×	104 0.9×	48 0.6×	23 0.3×	26	550

Countries citing papers authored by Pian Liu

Since Specialization

Citations

This map shows the geographic impact of Pian Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pian Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pian Liu more than expected).

Fields of papers citing papers by Pian Liu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pian Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pian Liu. The network helps show where Pian Liu may publish in the future.

Co-authorship network of co-authors of Pian Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Pian Liu. A scholar is included among the top collaborators of Pian Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pian Liu. Pian Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhang, Chen, et al.. (2025). The role of the mTOR pathway in breast cancer stem cells (BCSCs): mechanisms and therapeutic potentials. Stem Cell Research & Therapy. 16(1). 156–156. 12 indexed citations

Zhang, Dan, et al.. (2025). The role of fructose-1,6-bisphosphatase 1 on regulating the cancer progression and drug resistance. Discover Oncology. 16(1). 346–346.

Wang, Guo‐Liang, et al.. (2025). STAT3 orchestrates immune dynamics in hepatocellular carcinoma: A pivotal nexus in tumor progression. Critical Reviews in Oncology/Hematology. 207. 104620–104620. 4 indexed citations

Xue, Jun, S. Yang, Si‐Si Zhang, et al.. (2024). Deciphering the Multifaceted Immune Landscape of Unresectable Primary Liver Cancer to Predict Immunotherapy Response. Advanced Science. 11(47). e2309631–e2309631. 2 indexed citations

Liao, Xin, Tingting He, Pian Liu, et al.. (2024). Clinical Management in NSCLC Patients With EGFR Mutation After Osimertinib Progression With Unknown Resistance Mechanisms. The Clinical Respiratory Journal. 18(10). e70025–e70025. 2 indexed citations

Wang, Mengmeng, et al.. (2024). Advances in Targeted Drug Resistance Associated with Dysregulation of Lipid Metabolism in Hepatocellular Carcinoma. Journal of Hepatocellular Carcinoma. Volume 11. 113–129. 9 indexed citations

Liu, Pian, et al.. (2024). ZDHHC20 Activates AKT Signaling Pathway to Promote Cell Proliferation in Hepatocellular Carcinoma. Journal of Hepatocellular Carcinoma. Volume 11. 1763–1775. 4 indexed citations

Zhu, Liang, et al.. (2023). ZDHHC2-Mediated AGK Palmitoylation Activates AKT–mTOR Signaling to Reduce Sunitinib Sensitivity in Renal Cell Carcinoma. Cancer Research. 83(12). 2034–2051. 41 indexed citations

He, Lixin, Shu‐Mei Huang, Pian Liu, et al.. (2023). Lysosomal cyst(e)ine storage potentiates tolerance to oxidative stress in cancer cells. Molecular Cell. 83(19). 3502–3519.e11. 29 indexed citations

10.

Yan, Bin, et al.. (2023). The YTHDC1/GLUT3/RNF183 axis forms a positive feedback loop that modulates glucose metabolism and bladder cancer progression. Experimental & Molecular Medicine. 55(6). 1145–1158. 13 indexed citations

11.

Yang, Muwen, Lingzhi Kong, Shu‐Mei Huang, et al.. (2023). Inhibition of DPAGT1 suppresses HER2 shedding and trastuzumab resistance in human breast cancer. Journal of Clinical Investigation. 133(14). 14 indexed citations

12.

Wang, Haiqin, et al.. (2023). Overexpressed FAM111B degrades GSDMA to promote esophageal cancer tumorigenesis and cisplatin resistance. Cellular Oncology. 47(1). 343–359. 10 indexed citations

13.

Zhong, Wenjing, Yunting Jian, Chao Zhang, et al.. (2023). SHC4 orchestrates β-catenin pathway-mediated metastasis in triple-negative breast cancer by promoting Src kinase autophosphorylation. Cancer Letters. 582. 216516–216516. 6 indexed citations

14.

Zhang, Dan, Jing Tang, Yilin Wang, et al.. (2022). Global crotonylome reveals hypoxia-mediated lamin A crotonylation regulated by HDAC6 in liver cancer. Cell Death and Disease. 13(8). 717–717. 26 indexed citations

15.

Ye, Runyi, Huijuan Zeng, Nan Shao, et al.. (2021). Tripartite motif-containing 3 (TRIM3) enhances ER signaling and confers tamoxifen resistance in breast cancer. Oncogenesis. 10(9). 60–60. 10 indexed citations

16.

Wu, Xianqiu, Xin Zhang, Liang Yu, et al.. (2020). Zinc finger protein 367 promotes metastasis by inhibiting the Hippo pathway in breast cancer. Oncogene. 39(12). 2568–2582. 33 indexed citations

17.

Zhang, Chen, Bing-Fei Xu, Shi Lu, Ying Zhao, & Pian Liu. (2017). HN1 contributes to migration, invasion, and tumorigenesis of breast cancer by enhancing MYC activity. Molecular Cancer. 16(1). 90–90. 42 indexed citations

18.

Zhang, Chen, Shao-Hua Xie, Bing-Fei Xu, Shi Lu, & Pian Liu. (2017). Digitalis Use and the Risk of Breast Cancer: A Systematic Review and Meta-Analysis. Drug Safety. 40(4). 285–292. 6 indexed citations

19.

Zhang, Chen, Bing-Fei Xu, & Pian Liu. (2016). Addition of the p110α inhibitor BYL719 overcomes targeted therapy resistance in cells from Her2-positive-PTEN-loss breast cancer. Tumor Biology. 37(11). 14831–14839. 6 indexed citations

20.

Zhang, Ruiguang, Fang Zhu, Jinghua Ren, et al.. (2011). Beclin1/PI3K-Mediated Autophagy Prevents Hypoxia-Induced Apoptosis in EAhy926 Cell Line. Cancer Biotherapy and Radiopharmaceuticals. 26(3). 335–343. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shuzhen Chen Breakdown of academic impact, for papers by Allen Zhang Breakdown of academic impact, for papers by Ying Cheng Breakdown of academic impact, for papers by Macus Hao‐Ran Bao Breakdown of academic impact, for papers by Qian Qiao Breakdown of academic impact, for papers by Guangyuan Song Breakdown of academic impact, for papers by Anwen Liu